icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm
14 May, 2025 15:20

Court rules on von der Leyen’s secret Covid vaccine deal messages

The European Commission acted improperly by refusing to release communications with Pfizer to the media, the ruling states
Court rules on von der Leyen’s secret Covid vaccine deal messages

The European Commission wrongly denied the media access to secret text messages between its president, Ursula von der Leyen, and the CEO of pharma giant Pfizer, exchanged during negotiations of a multi-billion dollar Covid-19 vaccine deal, the Court of Justice of the European Union ruled on Wednesday.

The so-called “Pfizergate” case centers on a 2021 interview von der Leyen gave to the New York Times (NYT) in which she claimed she had been negotiating a deal for 900 million COVID vaccine shots with Pfizer CEO Albert Bourla via sms messages.

The NYT subsequently filed an access request for the messages, to which the EC claimed the texts, which have never been released, were not in its possession.

The court ruled that the EC “cannot merely state that it does not hold the requested documents but must provide credible explanations enabling the public and the Court to understand why those documents cannot be found.”

It also criticized the Commission for failing to justify why the texts were not retained and to clarify how they were deleted.

In response, the EC said it recognized the need for greater transparency and promised to issue a new decision with more detailed reasoning. It did not, however, commit to releasing the messages in question. The ruling can be appealed to the European Court of Justice.

A similar CJEU judgment last July found that the EC lacked transparency in how it negotiated vaccine contracts with Pfizer and AstraZeneca. The deals, signed in 2020 and 2021 and worth approximately €2.7 billion ($3 billion), were shielded from disclosure to European Parliament members on the grounds of protecting commercial interests.

Dear readers! Thank you for your vibrant engagement with our content and for sharing your points of view. Please note that we have switched to a new commenting system. To leave comments, you will need to register. We are working on some adjustments so if you have questions or suggestions feel free to send them to [email protected]. Please check our commenting policy
Podcasts
0:00
24:55
0:00
15:36